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Abstract—Nuclear transfer techniques have been proposed as a strategy for generating an unlimited supply of rejuvenated
and histocompatible stem cells for the treatment of cardiac diseases. For this purpose, c-kit–positive fetal liver stem cells
obtained from cloned embryos were injected in the border zone of infarcted mice to induce tissue reconstitution. Cloned
embryos were derived from somatic cell fusion between nuclei of cultured LacZ-positive fibroblasts and enucleated
oocytes of a different mouse strain. We report that regenerating myocardium replaced 38% of the scar at 1 month. The
rebuilt tissue expressed LacZ and was composed of myocytes and vessels connected with the coronary circulation.
Myocytes were functionally competent and expressed contractile proteins, desmin, connexin43, and N-cadherin. These
structural characteristics indicated that the new myocytes were electrically and mechanically coupled. Similarly, the
formed coronary arterioles and capillary structures contained blood and contributed, therefore, to tissue oxygenation.
Cardiac replacement resulted in an improvement of ventricular hemodynamics and in a reduction of diastolic wall stress.
These beneficial effects were obtained by stem cell transdifferentiation and commitment to the cardiac cell lineages.
Myocardial growth was independent from fusion of the injected stem cells with preexisting partner cells. In conclusion,
c-kit–positive stem cells derived by nuclear transfer cloning restore infarcted myocardium. Although problems currently
plague nuclear transplantation, including the potential for epigenetic and imprinting abnormalities, stem cells derived
from cloned embryos are sufficiently normal to repair damaged tissue in vivo. Importantly, the magnitude of myocardial
regeneration obtained in this study is significantly superior to that achieved with adult bone marrow cells. (Circ Res.
2004;94:820-827.)
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In the last few years, effort has been made to regenerateacutely infarcted myocardium. To restore function within
the dead portion of the heart, fetal, and adult myocytes,
skeletal myoblasts and bone marrow–derived immature myo-
cytes have been implanted in the infarct or delivered to the
ischemic tissue through the coronary circulation.1,2 Unfortu-
nately, these approaches failed to develop healthy myocardi-
um integrated structurally and functionally with the unaf-
fected region of the heart. More successful was the injection
in the border zone of bone marrow cells3 or the mobilization
of bone marrow cells into the circulation by systemic delivery
of cytokines.4 Both therapeutic modalities resulted in the
formation of new working myocardium and vascular struc-
tures connected with the primary coronary circulation. Re-
cently, a resident cardiac stem cell has been identified, and
after its expansion in vitro and injection in vivo, cardiac
regeneration was induced after infarction.5 However, these
forms of cellular therapy cannot be performed immediately
after the acute event and this delay may be critical for the
survival of patients. A 46% infarct results in a few days in
irreversible congestive heart failure and death in humans,6,7
indicating how dramatic can be the outcome of the disease
and how important is the possibility of rapid intervention,
myocardial regeneration, and reduction of infarct size.
An alternative strategy for the generation and storage of
cells to be used for the repair of injured myocardium is
offered by cloning techniques. The opportunity to reprogram
the nucleus of a fully differentiated adult cell and induce the
formation of an entirely different cell type constitutes a
unique tool that, in the future, could lead to the development
of novel treatments for cardiac diseases. Nuclear transfer–
generated cells and tissues have been successfully trans-
planted into animals without immune rejection.8 In addition,
nuclear transfer has been shown to extend cell lifespan and
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telomere length in animals cloned from senescent somatic
cells.9 The replicative lifespan of terminally differentiated
cells can be reversed by cloning, and most importantly, the
production of a uniform population of cells can be obtained
and its differentiation potential carefully characterized. This
approach requires cloning of pluripotent primitive cells able
to mature into myocytes and coronary vessels, ultimately
leading to the formation of adult contracting myocardium.
Bone marrow cells expressing c-kit, the receptor for the
Steel/stem cell factor, might give rise to cardiomyocytes,
arterioles, and capillaries after infarction as speculated but not
proven in previous studies.3,4 We chose to isolate c-kit–
positive cells from the liver of cloned embryos, because this
is the major embryonic site of hematopoiesis,10,11 preceding
the development of bone marrow. Cloned embryos were
derived from somatic cell fusion between nuclei of cultured
LacZ-positive fibroblasts and enucleated oocytes of a differ-
ent mouse strain. Liver c-kit–positive cells were injected near
an infarct in mice exposed to coronary artery ligation.
Animals were euthanized 1 month after surgery to determine
whether cardiac repair and reappearance of function occurred
in the infarcted ventricle at the completion of healing.
Materials and Methods
An expanded Materials and Methods can be found in an online data
supplement at http://circres.ahajournals.org.
Results
Myocardial Infarction and Cloned c-Kit–Positive
Cell Implantation
Donor cells were collected from the tail of 129/Sv-
ROSA:lacZ mice (Jackson Laboratory, Bar Harbor, Maine)
and their nuclei injected into enucleated oocytes to obtain
cloned embryos expressing LacZ. Subsequently, c-kit–posi-
tive cells were isolated by cell sorting from the liver of these
embryos (Figure 1). Myocardial infarction was induced by
occlusion of the left coronary artery in adult syngeneic
129/Sv mice. Four to six hours later, two injections of
approximately 10 000 c-kit–positive cells each were made in
the opposite regions of the border zone. At this interval,
parenchymal and vascular cells in the myocardium supplied
by the occluded coronary artery have reached irreversible
injury and death.2 Control groups consisted of infarcted mice
and sham-operated animals injected with physiological
saline.
Infarct size was measured by the fraction of myocytes lost
by the left ventricle (LV) and septum. In this manner, the
number of noninfarcted myocytes provided an anatomical
measurement that reflected the degree of cardiac function at
euthanasia.12 The dimension of the infarct was similar in the
two groups of mice. Infarct size comprised 565% (total
number of LV myocytes in sham-operated control animals,
2.720.30106; total number of LV myocytes in infarcted
animals, 1.180.13106; total number of LV myocytes lost
in infarcted animals, 1.540.13106) and 546% (total
number of LV myocytes in sham-operated control animals,
2.720.30106; total number of LV myocytes in infarcted
animals, 1.240.15106; total number of LV myocytes in
sham-operated control animals, 2.720.30106; total num-
ber of LV myocytes in infarcted animals, 1.180.13106;
total number of LV myocytes lost in infarcted animals,
1.480.15106) of myocytes in treated and untreated ani-
mals, respectively. In untreated mice, a compact scarred area
substituted the infarcted myocardium at 1 month after surgery
(Figures 2A through 2C). Connective tissue accumulation
consisted of both collagen types I and III and comprised most
of the entire left ventricular free wall. In contrast, myocardial
regeneration within the infarct was detected in all mice
injected with cloned c-kit–positive cells. Tissue reconstitution
involved new myocytes and vessels that together constituted
7.43.0 mm3 of myocardium. Tissue regeneration comprised
3811% of the infarcted scarred myocardium. The repairing
band of cloned c-kit–positive cell-derived myocardium was
present throughout the infarcted portion of the wall. It
occupied predominantly the inner and middle layers of the
damaged region of the ventricle (Figure 3A). The expression
of LacZ was identified in the entire band, confirming the
origin of the new myocardium from the implanted c-kit–
positive cells (Figures 3B through 3D).
Newly Formed Myocardium
The repairing myocardium was composed of myocytes
(765%), coronary arterioles (5.42.6%), capillaries
(5.72.9%), and other interstitium (12.93.0%). The num-
ber of arterioles and capillaries per mm2 of tissue was 288
and 24660, respectively. Because these measurements were
corrected for sample orientation, they corresponded to 28 mm
of arterioles and 246 mm of capillaries per mm3 of myocar-
dium, respectively. The length density of arterioles is one of
the critical factors of coronary vascular resistance and distri-
bution of blood flow to the myocardium.13 The large number
of arterioles might constitute an angiogenic response attempt-
ing to decrease vascular resistance in an area supplied by an
occluded coronary artery. Moreover, capillary numerical and
length densities are the determinants of oxygen availability
and diffusion within the tissue.12 Red blood cells, which were
stained by TER-119 antibody, were detected in arterioles and
capillaries (Figures 4A through 4D) distributed throughout
the newly formed myocardium. The endothelial lining of
arterioles and capillaries was identified by factor VIII or by
Figure 1. FACS profile of c-kit–positive cells isolated from livers
of cloned embryos. Left, PE-labeled rat anti-mouse IgG (nega-
tive control). Right, PE-labeled rat anti-mouse c-kit.
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Griffonia simplicifolia lectin labeling. The latter was used
when -gal was also established. The presence of red blood
cells in the lumen of the coronary vasculature after perfusion
fixation suggests that the forming vessels were connected
with the preexisting coronary circulation. The capillary-to-
myocyte ratio in the reconstituted myocardium was only 0.03.
This value was markedly lower than in the adult heart where
it approaches unity. In the regenerating band, there were 35
myocytes for each capillary, a condition found during late
fetal and early postnatal cardiac development.12
Forming Myocytes
Parenchymal cells within the rebuilding myocardium were
small in size, cylindrical in shape, and expressed contractile
proteins including cardiac myosin heavy chain, troponin I,
connexin43, and N-cadherin (Figures 5A through 5J). Con-
nexin43 is expressed at the level of the gap junctions14 and
N-cadherin at the level of the fascia adherens15 of the
intercalated discs. These new myocytes were positive for
-sarcomeric actin, -actinin, and desmin; they were the
progeny of cloned c-kit–positive cells because -gal was
identified in all cases.
Quantitatively, myocyte length, diameter, and cross-
sectional area averaged 354 m, 4.80.3 m, and 182
m2, respectively. Myocyte volume varied from 200 to 2700
m3 and had a mean value of 690 m3. Together, 8106
myocytes were accumulated within the infarcted heart in a
period of 1 month (Figure 6A); myocyte regeneration ex-
ceeded by more than 5-fold the magnitude of myocytes lost
with coronary occlusion. These cells were 97% smaller than
adult fully matured binucleated myocytes of sham-operated
control mice (24 0003400 m3). Myocyte hypertrophy did
not vary in the surviving myocardium of untreated and treated
animals. An average 96% increase in cell size (47 0007000
m3) was measured in both cases.
In addition to LacZ, BrdU was administrated in the
drinking water of treated mice throughout the period of
investigation to label the forming myocytes within the infarct
(Figures 6B through 6D). Moreover, the fraction of cycling
myocytes was measured at euthanasia by Ki67 labeling
Figure 2. Myocardial infarction. A
through C, Large infarct of the left ventri-
cle in an untreated mouse. Area defined
by a rectangle (A) is shown at higher
magnification in the two adjacent panels
(B and C). Accumulation of collagen type
III and type I (yellow fluorescence) within
the infarct (B; arrows) demonstrates the
lack of myocardial regeneration. Small
layer of viable myocytes (cardiac myosin,
red fluorescence) is present in the sub-
endocardium and subepicardium (C,
asterisk). Nuclei are stained by PI (green
fluorescence). IS indicates interventricu-
lar septum; MI, myocardial infarct. A,
bar1 mm; B and C, bars100 m.
Figure 3. Cloned c-kit–positive cells and
myocardial repair. A through D, Large
infarct of the left ventricle in a mouse
treated with cloned c-kit–positive cells.
Area defined by a rectangle (A) is shown
at higher magnification in the 3 adjacent
panels (B through D). Myocardial regen-
eration within the infarct (B) is docu-
mented by newly formed myocytes (car-
diac myosin, red fluorescence;
arrowheads). Expression of -gal is
shown in C by the distribution of blue
fluorescence in the same area (arrow-
heads). Combination of cardiac myosin
and -gal within the regenerating myo-
cardium (D) is demonstrated by magenta
fluorescence (arrowheads). IS indicates
interventricular septum; MI, myocardial
infarct. A, bar1 mm; B through D,
bars100 m.
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(Figures 6E through 6G). The objective was to establish
whether the level of cell replication was relatively low at 1
month, pointing to a prevailing differentiation phase of
myocytes at this time. Quantitatively, 933% of myocyte
nuclei were BrdU-positive, whereas only 51% expressed
Ki67. These results suggest that DNA synthesis and replica-
tion were attenuated in these new myocytes at the completion
of infarct healing. However, reduction in cell proliferation
occurred at a stage of cardiac repair in which the formed
myocytes had not reached yet the adult phenotype. Longer
intervals after infarction and cell implantation will have to be
examined to determine the actual long-term therapeutic po-
tential of cloned c-kit–positive cells.
DNA Content in Newly Formed Myocytes
Newly formed myocytes were 934% mononucleated and
74% binucleated. Sections of 10 m in thickness of the
regenerated myocardium were examined by confocal micros-
copy and the fluorescence intensity of propidium iodide
labeling of myocyte nuclei completely included in the section
was measured. Mouse lymphocytes were used for baseline
diploid DNA content. Both preparations were stained by Ki67
to evaluate separately DNA content in cycling and noncyc-
ling cells (Figure 6H). Noncycling myocyte and lymphocyte
nuclei had a 2n DNA content; greater values were restricted
to cycling Ki67-positive myocyte and lymphocyte nuclei,
excluding the formation of polyploidy during myocyte
growth.
Echocardiography and Ventricular Hemodynamics
To obtain information concerning the functional competence
of repairing myocytes, echocardiographic measurements
were collected at 15 and 29 days after coronary occlusion in
conscious unanesthetized mice.4,16,17 In the absence of im-
plantation of cloned c-kit–positive cells, contractile function
was not detected in the infarcted region of the wall at either
time interval. Conversely, in treated mice, wall motion was
minimally detectable at 15 days but became clearly evident at
29 days (Figures 7A through 7F). Therefore, the small
myocytes were electrically coupled and integrated mechani-
cally with the remaining portion of the unaffected left
ventricle. This was consistent with the expression of con-
nexin43 and N-cadherin and the partial restoration of con-
tractile activity within the infarcted myocardium. However,
fractional shortening and EF were not statistically different in
the two groups of infarcted animals (data not shown). These
observations suggest that the performance of the new tissue
was not sufficient to affect echocardiographic parameters of
ventricular function in these large infarcts. Conversely, he-
modynamic measurements at euthanasia showed an improve-
ment of LV end-diastolic pressure in infarcted treated mice.
Diastolic wall stress was also reduced by nearly 30% in this
group (Figures 8A through 8D).
The effects of tissue reconstitution on infarct size were
evaluated morphometrically. The newly formed tissue had
two consequences on the infarcted heart: it increased the
amount of functioning myocardium and decreased the extent
of tissue loss. The combination of these factors reduced
infarct size by 18%, from 56% to 46% of the LV and septum
(Figure 8E). The reduction of infarct size was not sufficient to
attenuate the remodeling of the postinfarcted heart. Chamber
diameter, chamber volume, the wall thickness-to-chamber
radius ratio, and the LV mass-to-chamber volume ratio were
not statistically different from those in infarcted untreated
mice (data not shown). Thus, cloned c-kit–positive cells
replaced dead myocardium, ameliorating the diastolic prop-
erties and loading condition of the infarcted heart.
Discussion
The results of the present study demonstrate that a pure
population of cloned c-kit–positive cells can repair an in-
farcted heart. This observation has no precedent and may
have important clinical implications. The ability to regenerate
the replicative lifespan of cells using cloning may have
therapeutic advantages. It allows the expansion of a popula-
tion of cells from a single cell resulting from gene targeting.
This, in turn, permits the production of uniform populations
of cells with one or more specific modifications. In addition,
Figure 4. Vessel formation in the regen-
erating myocardium of treated infarcted
hearts. A and B document in the thick
wall of a new arteriole the expression of
-gal (A; blue fluorescence, arrowheads)
and -gal and -smooth muscle actin in
smooth muscle cells (B; red-magenta
fluorescence, arrowheads). Erythrocytes
within the lumen are stained by TER-119
(B; yellow fluorescence). C and D, Thin
wall of 3 capillaries stained by -gal (C;
blue fluorescence, arrowheads) and by
-gal and Griffonia simplicifolia lectin (D;
magenta fluorescence, arrowheads). An
erythrocyte stained by TER-119 is pres-
ent in the lumen of one of the capillaries
(D; yellow fluorescence, arrow). Nuclei
are labeled by PI (A through D; green
fluorescence). Bars10 m.
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reprogramming by nuclear transfer makes feasible the in vitro
production of embryonic and fetal cell types, such as liver
cells. Animal studies suggest that murine fetal liver stem cells
can provide long-term hematopoietic re population of adult
mice, 5-times more effectively than adult bone marrow stem
cells.18,19 Similarly, fetal liver stem cells from cloned cows
have 10- to 100-fold selective advantage over adult hemato-
poietic stem cells in providing long-term hematopoietic
engraftment (unpublished data, 2004). As shown in this
study, a relatively small number of fetal liver stem cells
regenerated a significant portion of dead myocardium. How-
ever, there are numerous problems that currently plague
cloning, including the potential for epigenetic and imprinting
abnormalities in replacement cells created by somatic cell
nuclear transfer.20
A major question regarding therapeutic cloning is whether
stem cells derived from cloned embryos are sufficiently
normal to repair damaged tissue in vivo. The present findings
support this possibility and document for the first time that
fetal c-kit–positive cells replaced 38% of scarred tissue
chronically after infarction. Adult c-kit–positive bone marrow
cells regenerate infarcted myocardium but approximately
200 000 cells had to be injected to restore the dead tissue,3
whereas only 20 000 cells have been employed here. This
critical difference between the two protocols indicates that
the magnitude of cardiac repair obtained with stem cells from
cloned embryos was significantly superior to that achieved
with adult bone marrow cells.
An additional relevant question concerns the mechanisms
of tissue growth within the infarcted myocardium. Myocyte
replication and reconstitution of healthy contracting ventric-
ular muscle mass could have been the result of fusion of fetal
stem cells with existing myocytes and formation of hybrid
cells or the consequence of stem cell transdifferentiation and
cardiac lineage commitment. These two distinct pathways of
myocyte regeneration raise once more the controversial issue
of cell fusion versus transdifferentiation.21–24 However, sev-
eral lines of evidence argue against cell fusion as the cause for
the cardiac phenotype and pattern of gene expression of the
injected cells found in the present study. After permanent
Figure 5. Maturing myocytes in the
regenerating myocardium of treated
infarcted hearts. A through H, Expression
of -gal (A, C, E, and G; blue fluores-
cence) and specific contractile proteins
in new developing myocytes (B, D, F,
and H; red fluorescence). I and J, Con-
nexin43 (I; yellow fluorescence, arrow-
heads) and N-cadherin (J; yellow fluores-
cence, arrowheads) in forming myocytes
(I and J; myosin heavy chain, red fluores-
cence). Nuclei are labeled by PI (A through
J; green fluorescence). Bars10 m.
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coronary artery occlusion, all the cells in the supplied region
of the myocardium die in less than 5 hours.2 Essentially there
are no partner cells left for fusion. Additionally, adult
myocytes have an average volume of 24 0003400 m3. If
cell fusion occurred in our experimental condition, the newly
generated myocytes should have a cell volume of at least
24 000 m3 or larger. As illustrated in the distribution of the
volume of new myocytes, these cells reached a maximum size
of 2700 m3 and a minimum size of 200 m3. If we assume
that the variability of the volume measurement of the adult
ventricular mouse myocytes was three times the standard
deviation of the mean value (3400310 200 m3), the
resident cardiomyocytes would have a minimum volume of
13 800 m3 (24 000 m310 200 m3), which is 20-fold
larger than the mean volume of the newly formed cardiomyo-
cytes, 690 m3. Also, the reconstitution of dead myocardium
was characterized by the generation of 8 million new myo-
cytes. This number is 3-fold higher than the total number of
myocytes in the mouse left ventricle (2.7106) and 5-fold
higher than the number of myocytes lost after infarction
(1.54106). Donor-derived cells divide rapidly and exten-
sively, whereas in general, tetraploid cells divide slowly and
might not divide at all if one of the partners is a terminally
differentiated myocyte. Moreover, 92% of resident adult
mouse cardiomyocytes are binucleated and 6% are mono-
nucleated. Conversely, 93% of new myocytes are mononucle-
ated and only 7% binucleated. Cell fusion would imply the
generation of myocytes with two nuclei, one tetraploid and
the other diploid, or myocytes with three diploid nuclei. This
was not the case. Finally and most importantly, regenerating
myocytes had 2n DNA content, excluding unequivocally that
the process of cell fusion was implicated in cardiac repair.
An issue to be addressed concerns the structural properties
of the rebuilt myocardium. The new myocytes resembled
fetal-neonatal cells, which were paralleled by the formation
of a proportional number of capillaries and a larger number of
arterioles. This concept is based on developmental studies of
the heart in rodents.12,25 If this were a successful recapitula-
Figure 6. Proliferation of myocytes in the regenerating myocardium. A, Distribution of the volumes of newly generated myocytes. B
through D and E through G depict the same 2 fields. B through G, Localization of -gal in the cytoplasm (B and E; blue fluorescence)
and PI in nuclei (B and E; green fluorescence) of the regenerating myocardium of an infarcted treated mouse. C and F, Labeling of
BrdU (C; white fluorescence, arrowheads) and Ki67 (F; yellow fluorescence, arrowheads) in myocyte nuclei. D and G, Expression of
-gal and cardiac myosin heavy chain in myocyte cytoplasm (D and G; magenta fluorescence) and the combination of PI and BrdU (D;
green and white fluorescence) and PI and Ki67 (G; green and yellow fluorescence) in myocyte nuclei. Bars10 m. H, Distribution of
DNA content in noncycling (red) and cycling (Ki67-positive; green) myocyte and lymphocyte nuclei.
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tion of prenatal cardiac growth, myocytes would be expected
to increase rapidly in size and, over a period of nearly 2
months, reach the adult phenotype. The prevailing hypertro-
phic growth of myocytes should be accompanied by an
intense proliferative response of the capillary microvascula-
ture to preserve oxygen availability, diffusion, and transport
in the enlarged heart.25 This phenomenon has been carefully
defined in rodents and, in part, in humans.12,25 However, it
remains an unresolved problem in our experimental condi-
tions. The excessive number of arterioles might have had
significant implications in the restoration of blood flow in the
infarcted area. Coronary vascular resistance is inversely
correlated with the number of arterioles,13 suggesting that the
excessive growth of coronary vessels could have been re-
quired to connect the regenerating vasculature with the
primary unaffected coronary circulation. Thus, the system
needs to be perfected and the number of cells necessary to
optimize myocardial reconstitution has to be determined.
Importantly, more work has to be done to identify the
long-term outcome of this form of cardiac repair.
The cell population within the c-kit–positive subset of fetal
liver cells is, like its adult marrow counterpart, heteroge-
neous. The c-kit receptor is present on hematopoietic stem
and progenitors cells and is critical for their function as
revealed by the hematopoietic defects seen in loss of function
mutations at the mouse c-kit/white spotting locus.26 Endothe-
lial stem cells in fetal liver and adult bone marrow that can
participate in neovascularization are also c-kit–positive.27
Expression of c-kit on mesenchymal stem cells in marrow or
fetal liver has been reported in some but not all studies.28,29
Bone marrow–derived human mesenchymal stem cells have
been shown to differentiate into a cardiomyocyte phenotype
when injected into the adult murine heart.30 A more restricted
mesodermal stem cell, which was a common precursor of
both mesenchymal stem cells and hematopoietic stem cells,
has recently been isolated by c-kit sorting of early embryo
yolk sac and differentiated embryonic stem cells.31 The fetal
liver also contains hepatic stem cells or oval cell that are
c-kit–positive and normally differentiate into hepatocytes and
bile epithelial cells,32 but differentiation into pancreatic en-
docrine tissue has been reported.33 The pluripotent mesen-
chymal stem cell identified by Verfaillie and collaborators28
is c-kit–negative and is capable of cardiomyocyte differenti-
ation only when injected in the blastocyst.
In spite of these limitations and the caution that has to be
exercised with this type of approach, it is remarkable that
c-kit–positive cloned cells were capable of reconstituting
healthy myocardium with all its components. Transplanted
embryonic stem cells can differentiate into a variety of tissues
giving rise to cellular aggregates that do not always reproduce
the organized structure of an organ or tissue.34 It is reasonable
to postulate that cellular and/or extracellular factors produced
in the stressed myocardium of the border zone or in the
hostile environment of the ischemic area have been able to
direct and restrict the developmental potential of the im-
planted pluripotent cells. The cardiac repair obtained here via
nuclear transfer cloning represents, therefore, a model system
that can be used for the identification of the processes
regulating growth and differentiation of myocytes, endothe-
lial cells, and smooth muscle cells in the heart.
The present observations extend the early results of myo-
cardial tissue formation in vitro by nuclear transfer cloning
technique8 and provide an in vivo demonstration of the
effectiveness of this procedure. Somatic cell nuclear transfer
offers a clear advantage to the direct use of embryonic stem
cell–derived tissues.35 The latter promotes an immune re-
sponse with the inevitable consequence of graft rejection in
the absence of immunosuppressive therapy.36 However, the
approach used in this study cannot be applied clinically
because the cells were obtained from fetuses and ethical
principles require that preimplantation embryos not be al-
lowed to grow beyond the blastocyst stage.37,38
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Figure 7. Myocardial repair and echocar-
diography. A through F, M-mode echo-
cardiograms of untreated-infarcted (A
through C) and treated-infarcted (D
through F) hearts obtained at baseline (A
and D) and at 15 (B and E) and 29 (C
and F) days after coronary artery occlu-
sion. Arrowheads indicate partial restora-
tion of contractile activity within the
infarcted myocardium of a mouse treated
with cloned c-kit–positive cells.
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Figure 8. Myocardial repair and ventricular function. A through D, He-
modynamic parameters obtained before euthanasia. Results are
meanSD. Significant difference, P0.05 vs SO* and MI**. E, Effects
of myocardial regeneration on infarct size. On the basis of the volume
of LV in sham-operated (SO) mice and infarct size in untreated mice
(MI) and in treated mice (MI-T), the volume of myocardium destined to
remain (r) and destined to be lost (l) after coronary ligation was com-
puted. Volume of newly formed myocardium (f) was measured quanti-
tatively in treated mice. Myocardial regeneration increased the volume
of remaining myocardium (rf) and decreased the volume of lost
myocardium by the same amount of tissue (lf). Results are
meanSD. *Significant difference, P0.05 vs r and l alone.
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